Read + Share
Amedeo Smart
Independent Medical Education
Wang X, Zhang Y, Li A, Zhou C, et al. STYK1 as a targetable vulnerability enhances the efficacy of anti-PD-L1 therapy in pancreatic cancer. J Gastroenterol 2025 Sep 19. doi: 10.1007/s00535-025-02291.PMID: 40970928
Email
LinkedIn
Privacy Policy